[go: up one dir, main page]

JP5319130B2 - Keiko solvatochromic dye and method of use thereof - Google Patents

Keiko solvatochromic dye and method of use thereof Download PDF

Info

Publication number
JP5319130B2
JP5319130B2 JP2008023492A JP2008023492A JP5319130B2 JP 5319130 B2 JP5319130 B2 JP 5319130B2 JP 2008023492 A JP2008023492 A JP 2008023492A JP 2008023492 A JP2008023492 A JP 2008023492A JP 5319130 B2 JP5319130 B2 JP 5319130B2
Authority
JP
Japan
Prior art keywords
compound
group
alkyl group
fluorescent
dye
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2008023492A
Other languages
Japanese (ja)
Other versions
JP2008291210A (en
Inventor
幸司 山田
Original Assignee
五稜化学株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 五稜化学株式会社 filed Critical 五稜化学株式会社
Priority to JP2008023492A priority Critical patent/JP5319130B2/en
Publication of JP2008291210A publication Critical patent/JP2008291210A/en
Application granted granted Critical
Publication of JP5319130B2 publication Critical patent/JP5319130B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)

Description

この発明は、溶媒の極性により発光波長(即ち、発光色)が変わるケイ光ソルバトクロミック(solvatochromic)色素及びその使用法に関する。   The present invention relates to a fluorescent solvatochromic dye whose emission wavelength (that is, emission color) changes depending on the polarity of a solvent, and a method for using the same.

ケイ光ソルバトクロミック色素は、分子周辺の溶媒極性によって色の変わる色素であり、現在主に生体分子(特に脂質分子)のダイナミクスをケイ光顕微鏡でリアルタイムに高感度観測するためのプローブとして用いられている。それらの変色機構は特定の化学種との接触を必要としないので、他のケイ光色素では難しい抗原抗体反応や一塩基多型の識別が高感度にできる。
このケイ光ソルバトクロミック色素として、NBD、dansyl、prodan、Dapoxylなどがある。その中で最も性能が優れているのはDapoxylで、ソルバトクロミック色素としては珍しく長波長領域(370nm付近)に光励起が可能な吸収バンドがあり、ストークスシフトも大きく、ケイ光の量子収率も高い(非特許文献1)。
一方、本発明のケイ光ソルバトクロミック色素に近似のチオフェン誘導体は、非線形光学材料として知られている(非特許文献2)。
Fluorescent solvatochromic dye is a dye whose color changes depending on the solvent polarity around the molecule, and is currently used as a probe for observing the dynamics of biomolecules (especially lipid molecules) in real time with a fluorescent microscope. ing. Since these discoloration mechanisms do not require contact with a specific chemical species, antigen-antibody reactions and single nucleotide polymorphisms, which are difficult with other fluorescent dyes, can be highly sensitive.
Examples of this fluorescent solvatochromic dye include NBD, dansyl, prodan, and Dapoxyl. Among them, Dapoxyl has the best performance. It is a rare solvatochromic dye, and has an absorption band that can be photoexcited in the long wavelength region (near 370 nm), a large Stokes shift, and a quantum yield of fluorescence. High (Non-Patent Document 1).
On the other hand, a thiophene derivative approximate to the fluorescent solvatochromic dye of the present invention is known as a nonlinear optical material (Non-patent Document 2).

Photochemistry and Photobiology, 1997, 66(4): 424-431Photochemistry and Photobiology, 1997, 66 (4): 424-431 J. Heterocyclic Chem., 31, 1005-1009 (1994)J. Heterocyclic Chem., 31, 1005-1009 (1994)

しかし、一般に市販されているケイ光ソルバトクロミック色素(非特許文献1)は、他のケイ光色素に比べ励起波長が短波長であるため細胞や生体分子と用いた場合にこれらを光損傷する可能性があり、また、分子間に強い電荷移動相互作用が働きやすいため、溶解性が悪く合成や精製が困難であった。
そこで、本発明は、(1)励起波長が長波長で(2)モル吸光係数が大きく(3)ケイ光量子収率が高く(4)わずかな極性の変化でも大きく発光波長シフトする新規ケイ光ソルバトクロミック色素を提供することを目的とした。
However, commercially available fluorescent solvatochromic dyes (Non-patent Document 1) have a shorter excitation wavelength than other fluorescent dyes, so that they are photodamaged when used with cells and biomolecules. In addition, there is a possibility that strong charge transfer interaction between molecules tends to work, so that the solubility is poor and synthesis and purification are difficult.
Accordingly, the present invention provides (1) a long excitation wavelength, (2) a large molar extinction coefficient, (3) a high fluorescence quantum yield, and (4) a new fluorescence solver that greatly shifts the emission wavelength even with a slight change in polarity. The object was to provide a tochromic dye.

ケイ光ソルバトクロミック色素は、主に2種類の原料を縮環することにより合成できるが、その合成は困難であり、合成できたとしてもケイ光ソルバトクロミズムを示すとは限らない。そこで、本発明者らは、色素母骨格(チオフェン骨格又はフラン骨格)、電子供与部位及び電子吸引部位を別々に合成して、鈴木−宮浦クロスカップリング法(Chemical Reviews, 95巻, p2457-2483, 1995年)を利用してこれらを直結することにより、電子吸引部位としてスルホン酸をもつ様々なチオフェン誘導体又はフラン誘導体を合成した。
特に、そのスルホン酸基を嵩高いアルキルエステルとして保護することにより、有機溶媒への溶解性を大幅に向上させ、大量合成や精製を容易にした。この保護基は、DMF中で4級アンモニウム塩と反応させて定量的に脱保護することができ、水溶性でケイ光ソルバトクロミズムを示す種々の誘導体を合成することができた。更に、この誘導体から、ラベル化が可能なスルホン酸誘導体や、電子吸引性を高めて発光波長のシフト幅を大きくした様々な誘導体を合成することが可能である。
The fluorescent solvatochromic dye can be synthesized mainly by condensing two kinds of raw materials, but its synthesis is difficult, and even if synthesized, it does not necessarily show fluorescent solvatochromism. Therefore, the present inventors separately synthesized a chromophore skeleton (thiophene skeleton or furan skeleton), an electron donating site, and an electron withdrawing site to produce a Suzuki-Miyaura cross-coupling method (Chemical Reviews, Vol. 95, p2457-2483). , 1995), and various thiophene derivatives or furan derivatives having sulfonic acid as an electron withdrawing site were synthesized by directly connecting them.
In particular, by protecting the sulfonic acid group as a bulky alkyl ester, the solubility in organic solvents was greatly improved, facilitating mass synthesis and purification. This protecting group could be quantitatively deprotected by reacting with a quaternary ammonium salt in DMF, and it was possible to synthesize various derivatives that are water-soluble and exhibit fluorescent solvatochromism. Furthermore, from this derivative, it is possible to synthesize a sulfonic acid derivative that can be labeled, and various derivatives that have increased electron withdrawing property to increase the emission wavelength shift width.

即ち、本発明は、下式

Figure 0005319130
(式中、Xは酸素原子(−O−)又は硫黄原子(−S−)を表し、
mは1〜4の整数を表し、
は、下記(a)〜(e)のいずれかを表し、
(a)−O−R(式中、Rは、アルキル基の側鎖を有するアルキル基を表す。)
(b)−Y(式中、Yはハロゲン原子又はハロゲン化アルキル基を表す。)
(c)−NH(CHNH(式中、nは1〜14の整数を表す。)
(d)−NH(CHNHCO(CHY(式中、n及びoはそれぞれ1〜14の整数を表し、Yはハロゲン原子を表す。)
(e)−NH(CHCH(式中、nは1〜20の整数を表す。)
及びRは、それぞれ同じであっても異なってもよく、水素原子、アルコキシ基、アシルアミノ基、アルキル基、ハロゲン置換アルキル基、アミノ基、ヒドロキシ基又はハロゲン原子を表し、但し、R及びRは共同して芳香族若しくはエーテル結合を含んでもよい脂肪族の5、6又は8員環を形成してもよく、R及びRは、それぞれ同じであっても異なってもよく、水素原子又はアルキル基を表し、R及びRは、それぞれ同じであっても異なってもよく、水素原子、又は置換基を有していてもよいアルキル基を表し、但し、R及びRは共同して芳香族若しくは脂肪族の5員環又は6員環を形成してもよく、R及びRは共同して芳香族若しくは脂肪族の5員環又は6員環を形成してもよい。)で表されるケイ光ソルバトクロミック色素、又はこのケイ光ソルバトクロミック色素から成る極性検査薬である。 That is, the present invention has the following formula:
Figure 0005319130
(In the formula, X represents an oxygen atom (—O—) or a sulfur atom (—S—),
m represents an integer of 1 to 4,
R 1 represents any of the following (a) to (e):
(A) -O-R 8 (wherein, R 8 is. Represents an alkyl group having a side chain alkyl group)
(B) -Y (wherein Y represents a halogen atom or a halogenated alkyl group)
(C) —NH (CH 2 ) n NH 2 (wherein n represents an integer of 1 to 14)
(D) -NH (CH 2) n NHCO (CH 2) o Y ( wherein, n and o each represents an integer of 1 to 14, Y represents a halogen atom.)
(E) -NH (CH 2 ) n CH 3 (wherein n represents an integer of 1 to 20)
R 2 and R 3 may be the same or different and each represents a hydrogen atom, an alkoxy group, an acylamino group, an alkyl group, a halogen-substituted alkyl group, an amino group, a hydroxy group, or a halogen atom, provided that R 2 And R 3 together may form an aliphatic 5-, 6- or 8-membered ring which may contain an aromatic or ether bond, and R 4 and R 5 may be the same or different, respectively. Represents a hydrogen atom or an alkyl group, and R 6 and R 7 may be the same or different and each represents a hydrogen atom or an alkyl group which may have a substituent, provided that R 4 and R 6 may jointly form an aromatic or aliphatic 5-membered ring or 6-membered ring, and R 5 and R 7 together form an aromatic or aliphatic 5-membered ring or 6-membered ring May be. ) Or a polar test agent comprising this fluorescent solvatochromic dye.

また本発明は、このケイ光ソルバトクロミック色素を、アミノ基、水酸基、チオール基又はカルボキシル基を含有するアミノ酸を含むタンパク質若しくはペプチド又はポリ若しくはオリゴヌクレオチドに連結して形成されるケイ光ソルバトクロミック色素複合体である。
更に本発明は、これらのケイ光ソルバトクロミック色素やケイ光ソルバトクロミック色素複合体又はこれらを含む溶液に紫外線を照射する段階、及び該ケイ光ソルバトクロミック色素からの発光波長又は発光色を測定する段階から成る、該ケイ光ソルバトクロミック色素の周辺の極性を検査する方法である。
The present invention also provides a fluorescent solvatochromic dye formed by linking this fluorescent solvatochromic dye to a protein or peptide containing amino acids containing amino groups, hydroxyl groups, thiol groups or carboxyl groups, or poly or oligonucleotides. It is a dye complex.
Furthermore, the present invention provides a step of irradiating ultraviolet light to the fluorescent solvatochromic dye, the fluorescent solvatochromic dye complex or a solution containing them, and the emission wavelength or emission color from the fluorescent solvatochromic dye. It is a method for inspecting the polarity around the fluorescent solvatochromic dye comprising measuring.

本願発明のケイ光ソルバトクロミック色素は、様々な溶媒に対する溶解性が改良されている。その結果、精製が容易になるため、純度の高いケイ光ソルバトクロミック色素を容易に且つ大量に得ることが可能である。
また、本願発明のケイ光ソルバトクロミック色素は、従来の色素よりも励起波長が長波長であるため、細胞や生体分子の光損傷を極力防ぐことができ、例えば、細胞が生きたままの挙動の観測が可能になる。
このケイ光ソルバトクロミック色素は、脂質、タンパク質、核酸などに連結することができるため、生体分子などの微視的環境の変化をケイ光色変化で高感度に検出するケイ光プローブ等として用いることができる。
The fluorescent solvatochromic dye of the present invention has improved solubility in various solvents. As a result, since purification becomes easy, it is possible to easily obtain a large amount of a fluorescent solvatochromic dye having high purity.
In addition, since the fluorescent solvatochromic dye of the present invention has a longer excitation wavelength than conventional dyes, it can prevent photodamage of cells and biomolecules as much as possible. Can be observed.
Since this fluorescent solvatochromic dye can be linked to lipids, proteins, nucleic acids, etc., it is used as a fluorescent probe that detects changes in microscopic environments such as biomolecules with fluorescent color change with high sensitivity. be able to.

本発明で用いるケイ光ソルバトクロミック色素は下式で表される。

Figure 0005319130
Xは酸素原子(−O−)又は硫黄原子(−S−)を表す。
色素母骨格として、チオフェン骨格又はフラン骨格を用意して、鈴木−宮浦クロスカップリング法で電子供与部位及び電子吸引部位を連結することにより、電子吸引部位としてスルホン酸を持つチオフェン誘導体やフラン誘導体を容易に合成することができる。
また、色素母骨格として、複数のチオフェン骨格又はフラン骨格を含んでもよく、mは1〜4、好ましくは1又は2の整数を表す。 The fluorescent solvatochromic dye used in the present invention is represented by the following formula.
Figure 0005319130
X represents an oxygen atom (—O—) or a sulfur atom (—S—).
Prepare a thiophene skeleton or furan skeleton as the chromophoric skeleton, and connect the electron donating site and the electron withdrawing site by the Suzuki-Miyaura cross-coupling method to obtain a thiophene derivative or furan derivative having sulfonic acid as the electron withdrawing site. It can be easily synthesized.
In addition, the chromophore skeleton may include a plurality of thiophene skeletons or furan skeletons, and m represents an integer of 1 to 4, preferably 1 or 2.

は、まず下記(a)で表される。
(a)−O−R
式中、Rはアルキル基の側鎖を有するアルキル基を表す。Rは、好ましくは−(CH−C(Rで表され、Rは、それぞれ独立して、このうち少なくとも2つはアルキル基、好ましくは炭素数が1〜4の直鎖アルキル基であり、残りは水素原子を表し、oは0〜2の整数を表す。
一般にケイ光ソルバトクロミック色素は平面性が高く、分子間に強い電化移動相互作用が働き、溶媒に対する溶解性が低い。例えば、非特許文献2に記載のRがメチル基の化合物(compound 25)はDMFに溶解しない。しかし本発明のケイ光ソルバトクロミック色素は、上記のRが直鎖ではないアルキル基(即ち、嵩高いアルキル基)であるため、このような分子間相互作用を妨げる立体障害が生じ、溶媒に対する溶解性が上がる。その結果、例えば、溶液中でのケイ光測定が容易になり、製造時に精製が容易になるなどの利点が生じる。
R 1 is first represented by (a) below.
(A) -O-R 8
In the formula, R 8 represents an alkyl group having an alkyl group side chain. R 8 is preferably represented by — (CH 2 ) o —C (R 9 ) 3 , and each R 9 is independently at least two of which are alkyl groups, preferably having 1 to 4 carbon atoms. It is a linear alkyl group, the remainder represents a hydrogen atom, and o represents an integer of 0-2.
In general, a fluorescent solvatochromic dye has high planarity, a strong electromigration transfer interaction between molecules, and low solubility in a solvent. For example, a compound (compound 25) in which R 8 is a methyl group described in Non-Patent Document 2 does not dissolve in DMF. However, in the fluorescent solvatochromic dye of the present invention, since R 8 is an alkyl group that is not linear (that is, a bulky alkyl group), a steric hindrance that hinders such intermolecular interaction occurs, Increased solubility in As a result, there are advantages such as easy measurement of fluorescence in a solution and easy purification at the time of manufacture.

及びRは、それぞれ同じであっても異なってもよく、水素原子、アルコキシ基、アシルアミノ基、アルキル基、ハロゲン置換アルキル基、アミノ基、ヒドロキシ基又はハロゲン原子を表す。このアルコキシ基、アシルアミノ基及びアルキル基の炭素数はそれぞれ好ましくは1〜20、より好ましくは1〜4である。また、ハロゲン原子は、好ましくは、塩素原子又はフッ素原子である。
及びRとしては電子供与基が好ましい。このような電子供与基としては、例えば、アルコキシ基、アシルアミノ基、アルキル基、アミノ基又はヒドロキシ基、好ましくは、アルコキシ基、アルキル基又はヒドロキシ基が挙げられる。
また、R及びRは共同して芳香族若しくはエーテル結合を含んでもよい脂肪族の5、6又は8員環を形成してもよい。例えば、同一のチオフェン環又はフラン環上のR及びRは、共同して芳香族若しくはエーテル結合(−O−)を含んでもよい脂肪族の5員環又は6員環を形成してもよいし、更に、mが2以上の場合、あるチオフェン環又はフラン環上のR又はRは、隣接するチオフェン環又はフラン環上のR又はRと共同して、芳香族若しくはエーテル結合(−O−)を含んでもよい脂肪族の5、6又は8員環を形成してもよい。
R 2 and R 3 may be the same or different and each represents a hydrogen atom, an alkoxy group, an acylamino group, an alkyl group, a halogen-substituted alkyl group, an amino group, a hydroxy group, or a halogen atom. The alkoxy group, acylamino group and alkyl group each preferably have 1 to 20 carbon atoms, more preferably 1 to 4 carbon atoms. The halogen atom is preferably a chlorine atom or a fluorine atom.
R 2 and R 3 are preferably electron donating groups. Examples of such an electron donating group include an alkoxy group, an acylamino group, an alkyl group, an amino group, and a hydroxy group, preferably an alkoxy group, an alkyl group, and a hydroxy group.
R 2 and R 3 may jointly form an aliphatic 5-, 6- or 8-membered ring which may contain an aromatic or ether bond. For example, R 2 and R 3 on the same thiophene ring or furan ring may jointly form an aliphatic 5- or 6-membered ring that may contain an aromatic or ether bond (—O—). it may, further, when m is 2 or more, R 2 or R 3 on one thiophene ring or a furan ring cooperates with R 2 or R 3 on adjacent thiophene ring or a furan ring, aromatic or ether An aliphatic 5-, 6- or 8-membered ring which may contain a bond (—O—) may be formed.

及びRは、それぞれ同じであっても異なってもよく、水素原子又はアルキル基を表す。このアルキル基は好ましくは炭素数が1〜4のアルキル基である。
及びRは、それぞれ同じであっても異なってもよく、水素原子、又は置換基を有していてもよいアルキル基を表す。このアルキル基は好ましくは炭素数が1〜4のアルキル基であり、置換基としては水酸基、アミノ基、チオール基、スルホン酸基などが挙げられる。
但し、R及びRは共同して窒素原子を含む芳香族若しくは脂肪族の5員環又は6員環を形成してもよく、R及びRは共同して窒素原子を含む芳香族若しくは脂肪族の5員環又は6員環を形成してもよい。
R 4 and R 5 may be the same or different and each represents a hydrogen atom or an alkyl group. This alkyl group is preferably an alkyl group having 1 to 4 carbon atoms.
R 6 and R 7 may be the same or different and each represents a hydrogen atom or an alkyl group that may have a substituent. This alkyl group is preferably an alkyl group having 1 to 4 carbon atoms, and examples of the substituent include a hydroxyl group, an amino group, a thiol group, and a sulfonic acid group.
However, R 4 and R 6 may jointly form an aromatic or aliphatic 5-membered ring or 6-membered ring containing a nitrogen atom, and R 5 and R 7 together form an aromatic group containing a nitrogen atom. Alternatively, an aliphatic 5-membered ring or 6-membered ring may be formed.

上記のRが(a)−O−Rである色素から、公知の方法で様々な誘導体を容易に得ることができる。これらの誘導体は、そのまま又はタンパク質やヌクレオチド等に結合させることにより、様々な極性検査に用いることができる。その例をいくつか挙げる。 Various derivatives can be easily obtained by a known method from the dye in which R 1 is (a) —O—R 8 . These derivatives can be used for various polarity tests as they are or by binding them to proteins or nucleotides. Here are some examples.

上記のRが(a)−O−Rである色素(Rがネオペンチル基、R〜Rが水素原子、R及びRがメチル基である化合物を、以下「化合物1」という。)を例として、以下改変の例を説明する。反応を図1に示す。ただし、以下は説明を容易にするために化合物1を用いたが、本発明のこの他の化合物についても同様の反応が可能である。
化合物1(ネオペンチルエステル)は、スルホン酸が保護されているが、テトラメチルアンモニウムクロリド存在下DMF中160℃で攪拌することにより脱保護され、スルホン酸(化合物5)とすることができる(Tetrahedron Letters, vol.38(3),355-358 (1997))。スルホン酸(化合物5)は、5塩化リンと反応させて、酸クロリド(化合物6)に誘導化することができる。酸クロリド(化合物6)は、アミノ基と縮合しやすい。
A dye wherein R 1 is (a) —O—R 8 (R 8 is a neopentyl group, R 2 to R 5 are hydrogen atoms, and R 6 and R 7 are methyl groups is referred to as “compound 1”. An example of modification will be described below. The reaction is shown in FIG. However, in the following, Compound 1 was used for ease of explanation, but the same reaction is possible for other compounds of the present invention.
Compound 1 (neopentyl ester) is protected with sulfonic acid, but can be deprotected by stirring in DMF at 160 ° C. in the presence of tetramethylammonium chloride to give sulfonic acid (Compound 5) (Tetrahedron). Letters, vol. 38 (3), 355-358 (1997)). Sulfonic acid (Compound 5) can be derivatized to acid chloride (Compound 6) by reaction with phosphorus pentachloride. Acid chloride (compound 6) is easily condensed with an amino group.

この酸クロリド(化合物6)に、スルホン酸アミド結合を介して、様々な官能基を導入することもできる。例えば、ジアミン(例えば、エチレンジアミン)を用いて連結して、末端にアミノ基を有する化合物とすることができる(化合物7)。
また、この化合物7をブロモアセチルブロミドなどと反応させて、末端にハロゲン原子を有するハロアセチルアミド体(化合物8)を合成することができる。
さらに、酸クロリド(化合物6)をアルキルアミンと反応させて、アルキル鎖を連結することができる(化合物9)。
一般に、エステルに比べ、酸クロリドや酸アミドの方が電子吸引性は強い。一般に、色素の電子吸引性と電子供与性が強い場合には、吸収極大波長及びケイ光極大波長が共に大きく長波長シフトし、ストークスシフトが大くなる(非特許文献1)。そのため、化合物6〜9のケイ光色素は、化合物1よりも吸収及びケイ光波長が長波長で、ストークスシフトも大きくなる。
このように、上記の方法で機能性置換基を縮合して、更なる光学特性の向上及びラベル化部位の付与が可能な誘導体とすることができる。
Various functional groups can also be introduced into this acid chloride (compound 6) via a sulfonic acid amide bond. For example, a compound having an amino group at the terminal can be obtained by linking with diamine (for example, ethylenediamine) (compound 7).
Moreover, this compound 7 is made to react with bromoacetyl bromide etc., and the haloacetylamide body (compound 8) which has a halogen atom at the terminal can be synthesize | combined.
Furthermore, an acid chloride (compound 6) can be reacted with an alkylamine to link alkyl chains (compound 9).
In general, acid chloride and acid amide have stronger electron withdrawing properties than esters. In general, when the electron withdrawing property and electron donating property of the dye are strong, both the absorption maximum wavelength and the fluorescence maximum wavelength are greatly shifted by a long wavelength, and the Stokes shift is increased (Non-patent Document 1). Therefore, the fluorescent dyes of compounds 6 to 9 have longer absorption and fluorescence wavelengths than compound 1, and a large Stokes shift.
As described above, the functional substituent can be condensed by the above-described method to obtain a derivative capable of further improving optical properties and providing a labeled site.

即ち、上記Rが(a)−O−Rである色素から、上記Rが下記(b)〜(e)である色素化合物を誘導することができる。
(b)−Y(式中、Yはハロゲン原子を表す。このハロゲン原子としてはフッ素原子又は塩素原子が好ましい。)
(c)−NH(CHNH(式中、nは1〜14、好ましくは1〜4の整数を表す。)
(d)−NH(CHNHCO(CHY(式中、n及びoは独立して1〜14、好ましくは1〜4の整数を表し、Yはハロゲン原子又はハロゲン化アルキル基を表す。このハロゲン原子としてはフッ素原子又は塩素原子が好ましい。またこのハロゲン化アルキル基としては、炭素数1〜34、好ましくは1〜2のペルフルオロアルキル鎖、例えばペルフルオルメタンが挙げられる。)
(e)−NH(CHCH(式中、nは1〜20、好ましくは1〜4の整数を表す。)
That is, the dye compound in which R 1 is the following (b) to (e) can be derived from the dye in which R 1 is (a) —O—R 8 .
(B) -Y (wherein Y represents a halogen atom. The halogen atom is preferably a fluorine atom or a chlorine atom).
(C) —NH (CH 2 ) n NH 2 (wherein n represents an integer of 1 to 14, preferably 1 to 4)
(D) —NH (CH 2 ) n NHCO (CH 2 ) o Y (wherein n and o independently represent an integer of 1 to 14, preferably 1 to 4, Y represents a halogen atom or an alkyl halide) The halogen atom is preferably a fluorine atom or a chlorine atom, and the halogenated alkyl group is a perfluoroalkyl chain having 1 to 34 carbon atoms, preferably 1 to 2 carbon atoms, such as perfluoromethane. .)
(E) -NH (CH 2 ) n CH 3 (wherein n represents an integer of 1 to 20, preferably 1 to 4)

更に、このような色素化合物を、タンパク質を構成する様々なアミノ酸やヌクレオチドを構成する塩基に結合させることにより、複合体を形成させて、これらをラベル化することができる。その例を図2(1)〜(4)に示す。
(1)上記化合物6(酸クロリド)にジアミン化合物を連結し、酵素(トランスグルタミナーゼ)反応によりタンパク質のアミノ基含有アミノ酸(アスパラギン、グルタミン、リシン、アルギニン等)に連結することができる。その結果、タンパク質を上記Rが下記(f)であるラベル化されたタンパク質とすることができる。
(f)−NH−R10(式中、R10は、アミノ基含有アミノ酸を含むタンパク質から該アミノ基を除いたタンパク質残基、又はポリ若しくはオリゴヌクレオチドの塩基のアミノ基を除いたポリ若しくはオリゴヌクレオチド残基を表す。)
(2)このジアミン化合物を連結した化合物(化合物7)は、酵素(トランスグルタミナーゼ)反応により、タンパク質のアミノ基含有アミノ酸(アスパラギン、グルタミン、リシン、アルギニン等)に連結することができる。その結果、タンパク質を上記Rが下記(g)であるラベル化されたタンパク質とすることができる。
(g)−NH(CHNH−R10(式中、R10は、アミノ基含有アミノ酸を含むタンパク質から、該アミノ基を除いたタンパク質残基を表す。nは、例えば、1〜14、好ましくは1〜4の整数を表す。)
Furthermore, by binding such a dye compound to various amino acids and nucleotides constituting a protein, a complex can be formed and labeled. Examples thereof are shown in FIGS. 2 (1) to (4).
(1) A diamine compound can be linked to the compound 6 (acid chloride) and linked to an amino group-containing amino acid (asparagine, glutamine, lysine, arginine, etc.) of the protein by an enzyme (transglutaminase) reaction. As a result, the protein can be a labeled protein in which R 1 is the following (f).
(F) —NH—R 10 (wherein R 10 is a protein residue obtained by removing the amino group from a protein containing an amino group-containing amino acid, or poly or oligo from which the amino group of the base of poly or oligonucleotide is removed. Represents a nucleotide residue.)
(2) A compound (compound 7) obtained by linking this diamine compound can be linked to an amino group-containing amino acid (asparagine, glutamine, lysine, arginine, etc.) of a protein by an enzyme (transglutaminase) reaction. As a result, the protein can be a labeled protein in which R 1 is the following (g).
(G) -NH (CH 2) n NH-R 10 ( wherein, R 10 is a protein comprising an amino group-containing amino acids, .n representing the protein residue obtained by removing the amino group is, for example, 1 14 and preferably represents an integer of 1 to 4.)

(3)ブロモアセチルブロミドと反応させて色素化合物をチオール基含有アミノ酸(システイン等)に連結することができる。その結果、タンパク質を上記Rが下記(h)であるラベル化されたタンパク質とすることができる。
(h)−NH(CHNHCO(CH−S−R11(式中、R11は、チオール基含有アミノ酸を含むタンパク質から、該チオール基を除いたタンパク質残基を表す。n及びoは、それぞれ、例えば、1〜14、好ましくは1〜4の整数を表す。)
(4)上記化合物7(アミノ末端を持つ色素)と1−エチル−3−(3−ジメチルアミノプロピル)カルボジイミドなどのカルボジイミドでカルボキシル基を活性化したタンパク質を反応させると、カルボキシル基含有アミノ酸(アスパラギン酸等)に連結することができる。その結果、タンパク質を上記Rが下記(i)であるラベル化されたタンパク質とすることができる。
(i)−NH(CHNHSO−R12(式中、R12は、カルボキシル基含有アミノ酸を含むタンパク質から、該カルボキシル基を除いたタンパク質残基を表す。nは、例えば、1〜14、好ましくは1〜4の整数を表す。)
このほか、水酸基を有するアミノ酸(セリン、トレオニン、チロシン等)はアルデヒド基に誘導することにより、これら化合物と結合させてラベル化することができる。
(3) The dye compound can be linked to a thiol group-containing amino acid (cysteine or the like) by reacting with bromoacetyl bromide. As a result, the protein can be a labeled protein in which R 1 is the following (h).
(H) -NH (CH 2) n NHCO (CH 2) o -S-R 11 ( wherein, R 11 is a protein containing a thiol group-containing acids, represents a protein residue obtained by removing the thiol group. n and o each represent, for example, an integer of 1 to 14, preferably 1 to 4.)
(4) When the compound 7 (dye having an amino terminus) is reacted with a protein having a carboxyl group activated with carbodiimide such as 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide, a carboxyl group-containing amino acid (asparagine) Acid) and the like. As a result, the protein can be a labeled protein in which R 1 is the following (i).
(I) —NH (CH 2 ) n NHSO 2 —R 12 (wherein R 12 represents a protein residue obtained by removing the carboxyl group from a protein containing a carboxyl group-containing amino acid. -14, preferably an integer of 1-4.
In addition, amino acids having a hydroxyl group (serine, threonine, tyrosine, etc.) can be labeled by binding to these compounds by inducing to an aldehyde group.

このような色素複合体では、色素の周辺の極性変化を知ることができるため、例えば、以下のような用途に用いることができる。
(1)バイオイメージング用ケイ光色素の分野で、生体膜プローブとして有用である。即ち、アルキル鎖などの脂質分子に連結し、局所的な環境に応答してケイ光色が変化する分子膜プローブに利用することができる。合成法としては、スルホン酸クロリド体(例えば、図1の化合物6)に、末端にアミノ基を持つアルキルなどの脂質分子と反応させて目的のプローブ(例えば、図1の化合物9、上記(e)参照。)を得ることができる。この分子は、親水環境では長波長、疎水環境では短波長のケイ光を発するため、細菌細胞膜の検出・抗菌作用の評価・ドラッグデリバリーシステムの評価など生体膜ダイナミクスの高感度リアルタイム計測に用いることができる。
In such a dye complex, the change in polarity around the dye can be known, so that it can be used for the following applications, for example.
(1) It is useful as a biological membrane probe in the field of fluorescent dyes for bioimaging. That is, it can be used for a molecular membrane probe that is linked to a lipid molecule such as an alkyl chain and whose fluorescence color changes in response to a local environment. As a synthesis method, a sulfonic acid chloride compound (for example, compound 6 in FIG. 1) is reacted with a lipid molecule such as alkyl having an amino group at the terminal to react with a target probe (for example, compound 9 in FIG. See)). This molecule emits long-wavelength fluorescence in hydrophilic environments and short-wavelength fluorescence in hydrophobic environments, so it can be used for highly sensitive real-time measurement of biological membrane dynamics, such as detection of bacterial cell membranes, evaluation of antibacterial activity, and evaluation of drug delivery systems. it can.

(2)イムノアッセイ(免疫測定法)の分野で、抗原・抗体反応の高感度検出に有用である。即ち、抗原又は抗体の特定のアミノ酸残基にラベル化して、抗原抗体反応を高感度かつ高定量的に測定できるプローブ(例えば、図2(1)〜(4)、上記(f)〜(i)参照。)として利用することができる。抗原抗体認識部位の近傍の特定のアミノ酸部位にラベル化することができれば、反応前はタンパク表面に露出しているので長波長の、反応後は疎水場に取り込まれるので短波長のケイ光を発すると考えられる。ケイ光ソルバトクロミック色素は、特定の置換基の認識を必要としないので、さまざまな抗原抗体反応に汎用的に用いることができる。また、ケイ光ソルバトクロミック色素は、複数波長のケイ光を発するので、波長の強度比を算出することにより抗原抗体反応を高定量的に検出することができる。 (2) It is useful for highly sensitive detection of antigen / antibody reaction in the field of immunoassay. That is, a probe capable of labeling a specific amino acid residue of an antigen or antibody and measuring the antigen-antibody reaction with high sensitivity and quantitative (for example, FIG. 2 (1) to (4), the above (f) to (i ) Reference.) Can be used. If a specific amino acid site in the vicinity of the antigen-antibody recognition site can be labeled, it is exposed on the protein surface before the reaction, so that it has a long wavelength, and after the reaction, it is incorporated into a hydrophobic field, so it emits a short wavelength fluorescence. I think that. Since fluorescent solvatochromic dyes do not require recognition of specific substituents, they can be used universally for various antigen-antibody reactions. In addition, since the fluorescent solvatochromic dye emits multiple wavelengths of fluorescent light, the antigen-antibody reaction can be detected quantitatively by calculating the intensity ratio of the wavelengths.

(3)一塩基多型の検出においては、特定部位の塩基配列をケイ光色で高感度に識別するプローブとして利用できる。例えば、図3に示すように、スルホン酸クロリド体(例えば、図1の化合物6)に、核酸中の塩基から適切なスペーサー(例えば、メチレン鎖)を介して末端にアミノ基を持つ誘導体を反応させると、塩基の近傍をケイ光ラベル化することができる。既法により核酸アミダイトを合成し、固相合成により任意の塩基配列に組み込んだ核酸ポリマーを合成する。この任意の配列に、完全に相補的な核酸ポリマーをハイブリタイゼーションすれば、疎水場が形成されるのでケイ光は短波長であるが、塩基対のミスマッチが色素の近傍に存在すれば親水性が増すのでケイ光が長波長になり、塩基配列の識別がケイ光色によって高感度に識別できる。
なお、これらの用途に於て、本願発明の色素は、吸収波長が長波長であるため、励起光によるタンパク質やDNAの光損傷を避けられるため、従来の色素よりも有利である。
(3) In the detection of single nucleotide polymorphism, it can be used as a probe for identifying the base sequence of a specific site with a fluorescent color with high sensitivity. For example, as shown in FIG. 3, a derivative having an amino group at the terminal is reacted with a sulfonic acid chloride compound (for example, compound 6 in FIG. 1) from a base in a nucleic acid via an appropriate spacer (for example, a methylene chain). Then, the vicinity of the base can be fluorescently labeled. Nucleic acid amidites are synthesized by a conventional method, and a nucleic acid polymer incorporated into an arbitrary base sequence is synthesized by solid phase synthesis. Hybridization of a completely complementary nucleic acid polymer to this arbitrary sequence will form a hydrophobic field, so the fluorescence will be short wavelength, but hydrophilic if base pair mismatches are present in the vicinity of the dye. Therefore, the fluorescent light has a long wavelength, and the base sequence can be identified with high sensitivity by the fluorescent color.
In these applications, since the dye of the present invention has a long absorption wavelength, photodamage of protein and DNA due to excitation light can be avoided, which is advantageous over conventional dyes.

以下、実施例にて本発明を例証するが本発明を限定することを意図するものではない。
合成例1
本合成例では、4-(5-(4-(ジメチルアミノ)フェニル)-チオフェン-2-イル)-ベンゼンスルホン酸 2,2-ジメチルプロピル エステル(化合物1)を合成した。合成経路を図4に示す。
ネオペンチルアルコール(4.53g, 51.4 mmol)をクロロホルム50mLに溶かし、ピリジン(8.33 mL, 103 mmol)を加え、窒素気流下0℃で4-ブロモ-ベンゼンスルホン酸クロリド(東京化成工業株式会社製)(12.0g, 47.0 mmol)のクロロホルム溶液(20 mL)を45分かけて滴下した。その後、室温で23時間撹拌し、0.1%塩酸を加えた。ジエチルエーテルを加えて有機層を抽出した後、0.1%塩酸で1回、脱イオン水で3回、飽和食塩水で1回洗浄し、有機層を硫酸ナトリウムで乾燥した。溶媒留去後、残った固体をヘキサンで再結晶して、白色鱗片状晶の化合物2(4.17g, 13.6 mmol, 29%)を得た。以下に生成した化合物2(4-Bromo-benzenesulfonic acid 2,2-dimethylpropyl ester)の分析結果を示す。
1H-NMR (400MHz, CDCl3, TMS, r.t.) δ 7.76 (d, J = 9 Hz, 2H), 7.69 (d, J = 9 Hz, 2H), 3.69 (s, 2H), 0.91 (s, 9H).
The following examples illustrate the invention but are not intended to limit the invention.
Synthesis example 1
In this synthesis example, 4- (5- (4- (dimethylamino) phenyl) -thiophen-2-yl) -benzenesulfonic acid 2,2-dimethylpropyl ester (Compound 1) was synthesized. The synthesis route is shown in FIG.
Dissolve neopentyl alcohol (4.53 g, 51.4 mmol) in 50 mL of chloroform, add pyridine (8.33 mL, 103 mmol), and add 4-bromo-benzenesulfonic acid chloride (manufactured by Tokyo Chemical Industry Co., Ltd.) at 0 ° C. under a nitrogen stream ( A 12.0 g, 47.0 mmol) chloroform solution (20 mL) was added dropwise over 45 minutes. Thereafter, the mixture was stirred at room temperature for 23 hours, and 0.1% hydrochloric acid was added. Diethyl ether was added to extract the organic layer, which was then washed once with 0.1% hydrochloric acid, three times with deionized water and once with saturated brine, and the organic layer was dried over sodium sulfate. After distilling off the solvent, the remaining solid was recrystallized from hexane to obtain white scaly compound 2 (4.17 g, 13.6 mmol, 29%). The analysis result of the produced compound 2 (4-Bromo-benzenesulfonic acid 2,2-dimethylpropyl ester) is shown below.
1 H-NMR (400MHz, CDCl 3 , TMS, rt) δ 7.76 (d, J = 9 Hz, 2H), 7.69 (d, J = 9 Hz, 2H), 3.69 (s, 2H), 0.91 (s, 9H).

上記で得た化合物2(0.80g, 2.6 mmol)、ビス(ピナコラト)ジボロン(和光純薬工業株式会社製)(0.86g, 3.4 mmol)、[1,1'-ビス(ジフェニルホスフィノ)フェロセン]-ジクロロパラジウム(II) ジクロロメタン錯体(シグマアルドリッチジャパン株式会社製)(0.07g, 0.09 mmol)、酢酸カリウム(0.83g, 8.5 mmol)をDMSO 9.6 mLに溶かし、窒素気流下90℃で1時間半攪拌した。放冷後、クロロホルムを加え、有機層を3回洗浄した。塩析して、有機層を硫酸ナトリウムで乾燥した後、ろ過し、溶媒留去した。シリカゲルカラムクロマトグラフィー精製(ヘキサン:塩化メチレン=9:1→塩化メチレン→酢酸エチル:塩化メチレン=1:19)及び溶媒留去により、白色固体(化合物3)(0.75g, 2.1 mmol, 82%)を得た。以下に生成した化合物3(4-(4,4,5,5-テトラメチル-[1,3,2]ジオキサボロラン-2-イル)ベンゼンスルホン酸 2,2-ジメチルプロピルエステル)の分析結果を示す。
1H-NMR (400MHz, CDCl3, TMS, r.t.) δ 7.96 (d, J = 9 Hz, 2H), 7.87 (d, J = 9 Hz, 2H), 3.69 (s, 2H), 1.35 (s, 12H), 0.91 (s, 9H).
Compound 2 (0.80 g, 2.6 mmol) obtained above, bis (pinacolato) diboron (manufactured by Wako Pure Chemical Industries, Ltd.) (0.86 g, 3.4 mmol), [1,1′-bis (diphenylphosphino) ferrocene] -Dichloropalladium (II) dichloromethane complex (manufactured by Sigma Aldrich Japan Co., Ltd.) (0.07g, 0.09mmol) and potassium acetate (0.83g, 8.5mmol) are dissolved in 9.6mL of DMSO and stirred at 90 ° C for 1 hour and a half in a nitrogen stream did. After allowing to cool, chloroform was added and the organic layer was washed three times. After salting out, the organic layer was dried over sodium sulfate, filtered and evaporated. Purification by silica gel column chromatography (hexane: methylene chloride = 9: 1 → methylene chloride → ethyl acetate: methylene chloride = 1: 19) and evaporation of the solvent gave a white solid (compound 3) (0.75 g, 2.1 mmol, 82%) Got. The analysis results of Compound 3 (4- (4,4,5,5-tetramethyl- [1,3,2] dioxaborolan-2-yl) benzenesulfonic acid 2,2-dimethylpropyl ester) produced below are shown. .
1 H-NMR (400MHz, CDCl 3 , TMS, rt) δ 7.96 (d, J = 9 Hz, 2H), 7.87 (d, J = 9 Hz, 2H), 3.69 (s, 2H), 1.35 (s, 12H), 0.91 (s, 9H).

2,5-ジブロモチオフェン(和光純薬工業株式会社製)(40.0 mg, 16.5 mmol)と上記で得た化合物3(41.0 mg, 11.6 mmol)をトルエン5 mLとメタノール3 mLの混合溶媒に溶かし、1M 炭酸ナトリウム水溶液 1.3 mLとテトラキス(トリフェニルホスフィン)パラジウム(0)(和光純薬工業株式会社製)(23 mg, 20μmol)を加えた。真空脱気と窒素置換を3回繰り返し、80℃で3時間攪拌した。放冷後、クロロホルムに溶かし、2回脱イオン水で洗浄して、有機層を硫酸ナトリウムで乾燥した。ろ過して硫酸ナトリウムを取り除き、ろ液を溶媒留去した後、シリカゲルカラムクロマトグラフィー精製(クロロホルム)及び溶媒留去により、白色固体(化合物4)(32 mg, 8.2 mmol, 71%)を得た。以下に生成した化合物4(4-(5-ブロモ-チオフェン-2-イル)ベンゼンスルホン酸 2,2-ジメチルプロピルエステル)の分析結果を示す。
TLC;Rf = 0.09(溶離液;クロロホルム)
1H-NMR (400MHz, CDCl3, TMS, r.t.);δ 7.89 (d, J = 9 Hz, 2H), 7.66 (d, J = 9 Hz, 2H), 7.20 (d, J = 4 Hz, 1H), 7.09 (d, J = 4 Hz, 1H), 3.70 (s, 2H), 0.91 (s, 9H).
2,5-dibromothiophene (manufactured by Wako Pure Chemical Industries, Ltd.) (40.0 mg, 16.5 mmol) and compound 3 obtained above (41.0 mg, 11.6 mmol) were dissolved in a mixed solvent of 5 mL of toluene and 3 mL of methanol, 1.3 mL of 1M sodium carbonate aqueous solution and tetrakis (triphenylphosphine) palladium (0) (manufactured by Wako Pure Chemical Industries, Ltd.) (23 mg, 20 μmol) were added. Vacuum degassing and nitrogen substitution were repeated three times, and the mixture was stirred at 80 ° C. for 3 hours. After allowing to cool, it was dissolved in chloroform, washed twice with deionized water, and the organic layer was dried over sodium sulfate. After filtration to remove sodium sulfate, the filtrate was evaporated, and then purified by silica gel column chromatography (chloroform) and evaporated to give a white solid (compound 4) (32 mg, 8.2 mmol, 71%). . The analysis result of the produced compound 4 (4- (5-bromo-thiophen-2-yl) benzenesulfonic acid 2,2-dimethylpropyl ester) is shown below.
TLC; R f = 0.09 (eluent: chloroform)
1 H-NMR (400 MHz, CDCl 3 , TMS, rt); δ 7.89 (d, J = 9 Hz, 2H), 7.66 (d, J = 9 Hz, 2H), 7.20 (d, J = 4 Hz, 1H ), 7.09 (d, J = 4 Hz, 1H), 3.70 (s, 2H), 0.91 (s, 9H).

4-(ジメチルアミノ)フェニルボロン酸(シグマアルドリッチジャパン株式会社)(13.6 mg, 82 μmol)と上記で得た化合物4(32 mg, 82 μmol)をトルエン10 mLとメタノール 5 mLの混合溶媒に溶かし、0.66 M 炭酸ナトリウム水溶液 1.0 mLとテトラキス(トリフェニルホスフィン)パラジウム(0)(和光純薬工業株式会社製)(12 mg, 10 μmol)を加えた。真空脱気と窒素置換を3回繰り返し、80℃で3時間攪拌した。放冷後、クロロホルムに溶かし、2回脱イオン水で洗浄して、有機層を硫酸ナトリウムで乾燥した。ろ過して硫酸ナトリウムを取り除き、ろ液を溶媒留去した後、シリカゲルカラムクロマトグラフィー精製(クロロホルム)及び溶媒留去により、黄色粉末(化合物1)を得た。以下に生成した化合物1(4-(5-(4-(ジメチルアミノ)フェニル)-チオフェン-2-イル)ベンゼンスルホン酸 2,2-ジメチルプロピルエステル)の分析結果を示す。
TLC;Rf = 0.07(溶離液;クロロホルム)
1H-NMR (400MHz, CDCl3, TMS, r.t.);δ 7.86 (d, J = 9 Hz, 2H), 7.73 (d, J = 9 Hz, 2H), 7.52 (d, J = 9 Hz, 2H), 7.39 ( d, J = 4 Hz, 1H), 7.16 (d, J = 4 Hz, 1H), 3.70 (s, 2H), 3.01 (s, 6H), 0.91 (s, 9H).
4- (Dimethylamino) phenylboronic acid (Sigma Aldrich Japan Co., Ltd.) (13.6 mg, 82 μmol) and compound 4 obtained above (32 mg, 82 μmol) are dissolved in a mixed solvent of 10 mL of toluene and 5 mL of methanol. 0.66 M sodium carbonate aqueous solution 1.0 mL and tetrakis (triphenylphosphine) palladium (0) (manufactured by Wako Pure Chemical Industries, Ltd.) (12 mg, 10 μmol) were added. Vacuum degassing and nitrogen substitution were repeated three times, and the mixture was stirred at 80 ° C. for 3 hours. After allowing to cool, it was dissolved in chloroform, washed twice with deionized water, and the organic layer was dried over sodium sulfate. Sodium sulfate was removed by filtration, and the filtrate was evaporated to obtain a yellow powder (Compound 1) by silica gel column chromatography purification (chloroform) and solvent distillation. The analysis result of the produced compound 1 (4- (5- (4- (dimethylamino) phenyl) -thiophen-2-yl) benzenesulfonic acid 2,2-dimethylpropyl ester) is shown below.
TLC; R f = 0.07 (eluent: chloroform)
1 H-NMR (400 MHz, CDCl 3 , TMS, rt); δ 7.86 (d, J = 9 Hz, 2H), 7.73 (d, J = 9 Hz, 2H), 7.52 (d, J = 9 Hz, 2H ), 7.39 (d, J = 4 Hz, 1H), 7.16 (d, J = 4 Hz, 1H), 3.70 (s, 2H), 3.01 (s, 6H), 0.91 (s, 9H).

合成例2
本合成例では、4-(5-(4-(ジメチルアミノ)フェニル)-フラン-2-イル)-ベンゼンスルホン酸 2,2-ジメチルプロピル エステル(化合物13)を合成した。合成経路を図5に示す。
2,5-ジブロムフラン(東京化成工業株式会社製)(0.405g, 1.77mmol)、化合物3(0.6g, 1.69mmol)、4-(ジメチルアミノ)フェニルボロン酸(0.292g, 1.77mmol)をトルエン25ml、メタノール10mlに溶かし、水10mlに溶かしたNa2CO3(0.56g, 5.28mmol)とPd(PPh3)4(0.097g, 84μmol)を加え、更に脱気とN置換を3回行い、80℃で5時間攪拌した。放冷後、クロロホルムで3回抽出し、Na2SO4で乾燥させた。溶媒減圧除去し、シリカゲルクロマトグラフィー(溶離液;クロロホルム:ヘキサン=4:1)で分離精製し、黄色固体(化合物13)(0.137g, 20%)を得た。以下に生成した化合物13(4-(5-(4-(Dimethylamino)phenyl)-furan-2-yl)-benzenesulfonic acid 2,2-dimethylpropyl ester)の分析結果を示す。
TLC;Rf =0.23(クロロホルム:ヘキサン=4:1)
1H-NMR(400MHz, CDCl3, TMS, r.t.);δ 7.88(d, J = 9Hz, 2H), 7.82(d, J = 9Hz, 2H), 7.63(d, J = 9Hz, 2H), 6.90(d, J = 4Hz, 1H), 6.75(d, J = 9Hz, 2H), 6.56(d, J = 4Hz, 1H), 3.69(s, 2H), 3.00(s, 6H), 0.91(s, 9H).
Synthesis example 2
In this synthesis example, 4- (5- (4- (dimethylamino) phenyl) -furan-2-yl) -benzenesulfonic acid 2,2-dimethylpropyl ester (Compound 13) was synthesized. The synthesis route is shown in FIG.
2,5-Dibromofuran (Tokyo Chemical Industry Co., Ltd.) (0.405 g, 1.77 mmol), Compound 3 (0.6 g, 1.69 mmol), 4- (dimethylamino) phenylboronic acid (0.292 g, 1.77 mmol) in 25 ml of toluene Dissolve in 10 ml of methanol, add Na 2 CO 3 (0.56 g, 5.28 mmol) and Pd (PPh 3 ) 4 (0.097 g, 84 μmol) dissolved in 10 ml of water, and perform degassing and N 2 substitution three times. Stir at 80 ° C. for 5 hours. After allowing to cool, the mixture was extracted 3 times with chloroform and dried over Na 2 SO 4 . The solvent was removed under reduced pressure, and the residue was separated and purified by silica gel chromatography (eluent; chloroform: hexane = 4: 1) to obtain a yellow solid (compound 13) (0.137 g, 20%). The analysis result of the produced compound 13 (4- (5- (4- (Dimethylamino) phenyl) -furan-2-yl) -benzenesulfonic acid 2,2-dimethylpropyl ester) is shown below.
TLC; R f = 0.23 (chloroform: hexane = 4: 1)
1 H-NMR (400 MHz, CDCl 3 , TMS, rt); δ 7.88 (d, J = 9 Hz, 2H), 7.82 (d, J = 9 Hz, 2H), 7.63 (d, J = 9 Hz, 2H), 6.90 (d, J = 4Hz, 1H), 6.75 (d, J = 9Hz, 2H), 6.56 (d, J = 4Hz, 1H), 3.69 (s, 2H), 3.00 (s, 6H), 0.91 (s, 9H).

合成例3
本合成例では、4-(5- (4-(ジメチルアミノ)フェニル)-3,4-エチレンジオキシチオフェン-2-イル) ベンゼンスルホン酸 2,2-ジメチルプロピル エステル(化合物16)を合成した。合成経路を図6に示す。
3,4-エチレンジオキシチオフェン(シグマアルドリッチジャパン株式会社製)(1.42g, 10mmol)を50%酢酸のTHF溶液20mlに溶かし、氷冷下で50%酢酸のTHF溶液20mlに溶かしたN-ブロモスクシンイミド(和光純薬工業株式会社製)(3.74g, 21mmol)を1時間滴下添加した後、室温で2時間攪拌した。反応終了後、水100mlを加え、析出した固体を吸引ろ過で分離した。さらにろ液に水100mlを加え、析出した固体を吸引ろ過で分離した。これらの固体をさらに水で洗い、減圧下で乾燥して、白色結晶(化合物14)(2.67g, 89%)を得た。以下に生成した化合物14(2,5-Dibromo-3,4-ethylenedioxythiophene)の分析結果を示す。
TLC;Rf = 0.49(ヘキサン:酢酸エチル=3:1)
1H-NMR(400MHz, CDCl3, TMS, r.t.);δ 4.27(s,4H).
Synthesis example 3
In this synthesis example, 4- (5- (4- (dimethylamino) phenyl) -3,4-ethylenedioxythiophen-2-yl) benzenesulfonic acid 2,2-dimethylpropyl ester (Compound 16) was synthesized. . The synthesis route is shown in FIG.
3,4-Ethylenedioxythiophene (Sigma Aldrich Japan Co., Ltd.) (1.42 g, 10 mmol) dissolved in 20 ml of 50% acetic acid in THF and N-bromo dissolved in 20 ml of 50% acetic acid in THF under ice cooling Succinimide (manufactured by Wako Pure Chemical Industries, Ltd.) (3.74 g, 21 mmol) was added dropwise for 1 hour, followed by stirring at room temperature for 2 hours. After completion of the reaction, 100 ml of water was added, and the precipitated solid was separated by suction filtration. Further, 100 ml of water was added to the filtrate, and the precipitated solid was separated by suction filtration. These solids were further washed with water and dried under reduced pressure to obtain white crystals (compound 14) (2.67 g, 89%). The analysis result of the produced compound 14 (2,5-Dibromo-3,4-ethylenedioxythiophene) is shown below.
TLC; R f = 0.49 (hexane: ethyl acetate = 3: 1)
1 H-NMR (400 MHz, CDCl 3 , TMS, rt); δ 4.27 (s, 4H).

上記で得た化合物14(0.2g, 0.66mmol)、化合物3(0.187g, 0.528mmol)をトルエン20ml、メタノール10mlに溶かし、水5mlに溶かしたNa2CO3(0.106g, 1.0mmol)とPd(PPh3)4(0.038g, 33μmol)を加え、脱気とN置換を3回行い、80℃で4時間攪拌した。
放冷後、クロロホルムで3回抽出し、Na2SO4で乾燥させた。溶媒減圧除去し、シリカゲルクロマトグラフィー(溶離液;クロロホルム)で分離精製し、黄色固体(化合物15)(0.148g, 63%)を得た。以下に生成した化合物15(4-(5-Bromo-3,4-ethylenedioxythiophen-2-yl) benzenesulfonic acid 2,2-dimethylpropyl ester)の分析結果を示す。
TLC;Rf = 0.18(ヘキサン:クロロホルム=1:1)
1H-NMR(400MHz, CDCl3, TMS, r.t.);δ 7.92(d, J = 9Hz, 2H), 7.88(d, J = 9Hz, 2H), 4.45(s, 4H), 3.67(s, 2H), 0.92(s, 9H).
Compound 14 (0.2 g, 0.66 mmol) and compound 3 (0.187 g, 0.528 mmol) obtained above were dissolved in 20 ml of toluene and 10 ml of methanol, and Na 2 CO 3 (0.106 g, 1.0 mmol) and Pd dissolved in 5 ml of water. (PPh 3 ) 4 (0.038 g, 33 μmol) was added, degassing and N 2 substitution were performed 3 times, and the mixture was stirred at 80 ° C. for 4 hours.
After allowing to cool, the mixture was extracted 3 times with chloroform and dried over Na 2 SO 4 . The solvent was removed under reduced pressure, and the residue was separated and purified by silica gel chromatography (eluent: chloroform) to obtain a yellow solid (Compound 15) (0.148 g, 63%). The analysis result of the compound 15 (4- (5-Bromo-3,4-ethylenedioxythiophen-2-yl) benzenesulfonic acid 2,2-dimethylpropyl ester) produced below is shown.
TLC; R f = 0.18 (hexane: chloroform = 1: 1)
1 H-NMR (400 MHz, CDCl 3 , TMS, rt); δ 7.92 (d, J = 9 Hz, 2H), 7.88 (d, J = 9 Hz, 2H), 4.45 (s, 4H), 3.67 (s, 2H ), 0.92 (s, 9H).

上記で得た化合物15(0.148g, 0.33mmol)、4-(ジメチルアミノ)フェニルボロン酸(0.065g, 0.40mmol)をトルエン20ml、メタノール10mlに溶かし、水5mlに溶かしたNa2CO3(0.07g, 0.66mmol)とPd(PPh3)4(0.03g, 26μmol)を加え、更に脱気とN置換を3回行い、80℃で21時間攪拌した。放冷後、クロロホルムで3回抽出し、Na2SO4で乾燥させた。溶媒減圧除去し、シリカゲルクロマトグラフィー(溶離液;クロロホルム:ヘキサン=99:1)で分離精製し、黄色固体(化合物16)(0.0153g, 10%)を得た。以下に生成した化合物16(4-(5- (4-(Dimethylamino)phenyl)-3,4-ethylenedioxythiophen-2-yl) benzenesulfonic acid 2,2-dimethylpropyl ester)の分析結果を示す。
TLC;Rf = 0.43(クロロホルム:酢酸エチル=99:1)
1H-NMR(400MHz, CDCl3, TMS, r.t.);δ 7.87(d, J = 9Hz, 2H), 7.82(d, J = 9Hz, 2H), 7.63(d, J = 9Hz, 2H), 6.74(d, J = 9Hz, 2H), 4.40(d, J = 5 Hz, 2H), 4.36 (d, J = 5 Hz, 2H), 3.67(s, 2H), 2.99(s, 6H), 0.91(s, 9H).
Compound 15 (0.148 g, 0.33 mmol), 4- (dimethylamino) phenylboronic acid (0.065 g, 0.40 mmol) obtained above was dissolved in 20 ml of toluene and 10 ml of methanol, and Na 2 CO 3 (0.07 dissolved in 5 ml of water). g, 0.66 mmol) and Pd (PPh 3 ) 4 (0.03 g, 26 μmol) were added, and degassing and N 2 substitution were further performed three times, followed by stirring at 80 ° C. for 21 hours. After allowing to cool, the mixture was extracted 3 times with chloroform and dried over Na 2 SO 4 . The solvent was removed under reduced pressure, and the residue was separated and purified by silica gel chromatography (eluent; chloroform: hexane = 99: 1) to obtain a yellow solid (Compound 16) (0.0153 g, 10%). The analysis result of the produced compound 16 (4- (5- (4- (Dimethylamino) phenyl) -3,4-ethylenedioxythiophen-2-yl) benzenesulfonic acid 2,2-dimethylpropyl ester) is shown below.
TLC; R f = 0.43 (chloroform: ethyl acetate = 99: 1)
1 H-NMR (400 MHz, CDCl 3 , TMS, rt); δ 7.87 (d, J = 9 Hz, 2H), 7.82 (d, J = 9 Hz, 2H), 7.63 (d, J = 9 Hz, 2H), 6.74 (d, J = 9Hz, 2H), 4.40 (d, J = 5 Hz, 2H), 4.36 (d, J = 5 Hz, 2H), 3.67 (s, 2H), 2.99 (s, 6H), 0.91 ( s, 9H).

合成例4
本合成例では、(2-(4-(5-(4-(ジメチルアミノ)フェニル)チオフェン-2-イル)ベンゼンスルホン酸アミノ)エチル)カルバミン酸 tert-ブチルエステル(化合物19)を合成した。合成経路を図7に示す。
4-ブロモ-ベンゼンスルホン酸クロリド(東京化成工業株式会社製)(1.60g, 6.3mmol) を塩化メチレン60mlに溶かし、塩化メチレン50mlとトリエチルアミン 2 ml(14mmol)の混合溶液に溶かしたN-Boc-ethylenediamine(和光純薬工業株式会社製)(0.84g, 5.2mmol)に1時間滴下添加した後、25時間攪拌した。反応終了後、水50mlを加え洗浄し、塩化メチレンで3回抽出し、Na2SO4で乾燥させた。溶媒減圧除去し、シリカゲルクロマトグラフィー(溶離液;クロロホルム:酢酸エチル=10:1→6:1)で分離精製し、白色固体(化合物17)(1.81g, 91%)を得た。以下に生成した化合物17((2-(4-Bromo-benzenesulfonylamino)ethyl)carbamic acid tert-butyl ester)の分析結果を示す。
TLC;Rf = 0.38(ヘキサン:酢酸エチル=3:1)
1H-NMR(400MHz, CDCl3, TMS, r.t.); δ 7.71(d, J = 8Hz, 2H), 7.64(d, J = 8Hz, 2H), 5.30.(s, 1H), 4.78(s, 1H), 3.22(t, J = 5Hz, 2H), 3.07(d, J = 5Hz, 2H), 1.43(s,9H).
Synthesis example 4
In this synthesis example, (2- (4- (5- (4- (dimethylamino) phenyl) thiophen-2-yl) benzenesulfonic acid amino) ethyl) carbamic acid tert-butyl ester (Compound 19) was synthesized. The synthesis route is shown in FIG.
4-Bromo-benzenesulfonic acid chloride (Tokyo Chemical Industry Co., Ltd.) (1.60 g, 6.3 mmol) dissolved in 60 ml of methylene chloride and N-Boc- dissolved in a mixed solution of 50 ml of methylene chloride and 2 ml (14 mmol) of triethylamine After adding dropwise to ethylenediamine (manufactured by Wako Pure Chemical Industries, Ltd.) (0.84 g, 5.2 mmol) for 1 hour, the mixture was stirred for 25 hours. After completion of the reaction, 50 ml of water was added for washing, followed by extraction three times with methylene chloride and drying over Na 2 SO 4 . The solvent was removed under reduced pressure, and the residue was separated and purified by silica gel chromatography (eluent; chloroform: ethyl acetate = 10: 1 → 6: 1) to obtain a white solid (compound 17) (1.81 g, 91%). The analysis result of the produced compound 17 ((2- (4-Bromo-benzenesulfonylamino) ethyl) carbamic acid tert-butyl ester) is shown below.
TLC; R f = 0.38 (hexane: ethyl acetate = 3: 1)
1 H-NMR (400 MHz, CDCl 3 , TMS, rt); δ 7.71 (d, J = 8 Hz, 2H), 7.64 (d, J = 8 Hz, 2H), 5.30. (S, 1H), 4.78 (s, 1H), 3.22 (t, J = 5Hz, 2H), 3.07 (d, J = 5Hz, 2H), 1.43 (s, 9H).

上記で得た化合物17(0.20g, 0.53mmol)と2.5-チオフェンジボロン酸(和光純薬工業株式会社製)(0.12g, 0.7mmol)をトルエン25mlとメタノール15mlの混合溶媒に溶かし、Na2CO3(0.223g, 2.1mmol)の水溶液5mlとPd(PPh3)4(0.04g, 35μmol)を加え、脱気とN置換を3回行い、80℃で4時間攪拌した。放冷後、クロロホルムで3回抽出し、Na2SO4で乾燥させた。溶媒減圧除去し、シリカゲルクロマトグラフィー(溶離液;クロロホルム:酢酸エチル=43:7)で分離精製し、白色粉末(化合物18)(0.267g, 89%)を得た。以下に生成した化合物18((2-(4-(5-(dihydroxyboryl)thiophen-2-yl)benzenesulfonylamino)ethyl)carbamic acid tert-butyl ester)の分析結果を示す。
TLC;Rf = 0.23(クロロホルム:酢酸エチル=8:1)
1H-NMR(400MHz, CDCl3, TMS, r.t.); δ 7.71(d, J = 9Hz, 2H), 7.64(d, J = 9Hz, 2H), 7.54(d, J = 5Hz, 1H), 7.47(d, J = 5Hz, 1H), 5.36.(s, 1H), 4.82.(s, 1H), 3.24(d, J = 5Hz, 2H), 3.10(d, J = 5Hz, 2H), 1.43(s, 9H).
Compound 17 (0.20 g, 0.53 mmol) obtained above and 2.5-thiophene diboronic acid (manufactured by Wako Pure Chemical Industries, Ltd.) (0.12 g, 0.7 mmol) were dissolved in a mixed solvent of 25 ml of toluene and 15 ml of methanol, and Na 2 5 ml of an aqueous solution of CO 3 (0.223 g, 2.1 mmol) and Pd (PPh 3 ) 4 (0.04 g, 35 μmol) were added, and degassing and N 2 substitution were performed three times, followed by stirring at 80 ° C. for 4 hours. After allowing to cool, the mixture was extracted 3 times with chloroform and dried over Na 2 SO 4 . The solvent was removed under reduced pressure, and the residue was separated and purified by silica gel chromatography (eluent; chloroform: ethyl acetate = 43: 7) to obtain a white powder (Compound 18) (0.267 g, 89%). The analysis result of the produced compound 18 ((2- (4- (5- (dihydroxyboryl) thiophen-2-yl) benzenesulfonylamino) ethyl) carbamic acid tert-butyl ester) is shown below.
TLC; R f = 0.23 (chloroform: ethyl acetate = 8: 1)
1 H-NMR (400 MHz, CDCl 3 , TMS, rt); δ 7.71 (d, J = 9 Hz, 2H), 7.64 (d, J = 9 Hz, 2H), 7.54 (d, J = 5 Hz, 1H), 7.47 (d, J = 5Hz, 1H), 5.36. (s, 1H), 4.82. (s, 1H), 3.24 (d, J = 5Hz, 2H), 3.10 (d, J = 5Hz, 2H), 1.43 ( s, 9H).

上記で得た化合物18(0.54g, 1.27mmol)、4-ブロモ-N,N-ジメチルアニリン(シグマアルドリッチジャパン株式会社製)(0.30g, 1.5mmol)をトルエン35mlとメタノール25mlの混合溶媒に溶かし、Na2CO3(0.27g, 2.54mmol)水溶液 10mlとPd(PPh3)4(0.117g, 101μmol)を加え、更に脱気とN置換を3回行い、80℃で22時間攪拌した。放冷後、クロロホルムで3回抽出し、Na2SO4で乾燥させた。溶媒減圧除去し、シリカゲルクロマトグラフィー(溶離液;クロロホルム:酢酸エチル=4:1)で分離精製し、白色粉末(化合物19)(0.35g, 56%)を得た。以下に生成した化合物19((2-(4-(5-(4-(dimethylamino)phenyl)thiophen-2-yl)benzenesulfonylamino)ethyl)carbamic acid tert-butyl ester)の分析結果を示す。
TLC;Rf = 0.36(クロロホルム:酢酸エチル=4:1)
1H-NMR(400MHz, CDCl3, TMS, r.t.); δ 7.84(d, J = 8Hz, 2H), 7.72(d, J = 8Hz,2H), 7.62(d, J = 8Hz, 2H), 7.52(d, J = Hz, 1H), 7.42(d, J = 8Hz, 1H), 6.79(d, J = 8Hz,2H) 5.26(s, 1H), 4.81(s, 1H), 3.25(d, J = 4.8Hz, 2H), 3.09(d, J = 4.8Hz, 2H), 2.97(s,6H), 1.43(s, 9H).
Compound 18 (0.54 g, 1.27 mmol) obtained above and 4-bromo-N, N-dimethylaniline (manufactured by Sigma-Aldrich Japan) (0.30 g, 1.5 mmol) were dissolved in a mixed solvent of 35 ml of toluene and 25 ml of methanol. Then, 10 ml of an aqueous solution of Na 2 CO 3 (0.27 g, 2.54 mmol) and Pd (PPh 3 ) 4 (0.117 g, 101 μmol) were added, and degassing and N 2 substitution were further performed three times, followed by stirring at 80 ° C. for 22 hours. After allowing to cool, the mixture was extracted 3 times with chloroform and dried over Na 2 SO 4 . The solvent was removed under reduced pressure, and the residue was separated and purified by silica gel chromatography (eluent; chloroform: ethyl acetate = 4: 1) to obtain a white powder (compound 19) (0.35 g, 56%). The analysis result of the produced compound 19 ((2- (4- (5- (4- (dimethylamino) phenyl) thiophen-2-yl) benzenesulfonylamino) ethyl) carbamic acid tert-butyl ester) is shown below.
TLC; R f = 0.36 (chloroform: ethyl acetate = 4: 1)
1 H-NMR (400 MHz, CDCl 3 , TMS, rt); δ 7.84 (d, J = 8 Hz, 2H), 7.72 (d, J = 8 Hz, 2H), 7.62 (d, J = 8 Hz, 2H), 7.52 (d, J = Hz, 1H), 7.42 (d, J = 8Hz, 1H), 6.79 (d, J = 8Hz, 2H) 5.26 (s, 1H), 4.81 (s, 1H), 3.25 (d, J = 4.8Hz, 2H), 3.09 (d, J = 4.8Hz, 2H), 2.97 (s, 6H), 1.43 (s, 9H).

合成例5
本合成例では、4-(5'-(4-(ジメチルアミノ)フェニル)-2,2'-ビチオフェン-5-イル) ベンゼンスルホン酸 2,2-ジメチルプロピル エステル(化合物21)を合成した。合成経路を図8に示す。
5,5'-ジブロモ-2,2'-ビチオフェン(和光純薬工業株式会社製)(0.324 g, 1.00 mmol)、化合物3 (0.248 g, 0.70 mmol)をトルエン20 mlとメタノール12 mlの混合溶媒に溶解させ、更に1.0 M Na2CO3 aq 5 mlと Pd(PPh3)4 (0.066g, 57μmol)を加え、脱気と N置換を3回行い、80℃で4時間半攪拌した。放冷後、トルエンを加えて有機層を抽出し、水と飽和食塩水で洗浄した後 Na2SO4で乾燥させた。溶媒減圧除去し、シリカゲルクロマトグラフィー(溶離液;トルエン)で精製し、黄色固体(化合物20) (0.137g, 43%)を得た。以下に生成した化合物20(4-(5'-Bromo-2,2'-Bithiophen-5-yl) benzenesulfonic acid 2,2-dimethylpropyl ester)の分析結果を示す。
TLC; Rf = 0.07 (トルエン)
1H-NMR (400 MHz, CDCl3, TMS, r.t.); δ 7.89 (d, J = 8 Hz, 2H), 7.72 (d, J = 8 Hz, 2H), 7.35 (d, J = 4 Hz, 1H), 7.12 (d, J = 4 Hz, 1H), 7.00 (d, J = 4 Hz, 1H), 6.98 (d, J = 4 Hz, 1H), 3.71 (s, 2H), 0.92 (s, 9H).
Synthesis example 5
In this synthesis example, 4- (5 ′-(4- (dimethylamino) phenyl) -2,2′-bithiophen-5-yl) benzenesulfonic acid 2,2-dimethylpropyl ester (Compound 21) was synthesized. The synthesis route is shown in FIG.
5,5'-Dibromo-2,2'-bithiophene (manufactured by Wako Pure Chemical Industries, Ltd.) (0.324 g, 1.00 mmol), Compound 3 (0.248 g, 0.70 mmol) in a mixed solvent of 20 ml of toluene and 12 ml of methanol Then, 1.0 M Na 2 CO 3 aq 5 ml and Pd (PPh 3 ) 4 (0.066 g, 57 μmol) were added, degassing and N 2 substitution were performed 3 times, and the mixture was stirred at 80 ° C. for 4 hours and a half. After allowing to cool, toluene was added to extract the organic layer, washed with water and saturated brine, and dried over Na 2 SO 4 . The solvent was removed under reduced pressure, and the residue was purified by silica gel chromatography (eluent: toluene) to obtain a yellow solid (Compound 20) (0.137 g, 43%). The analysis result of the produced compound 20 (4- (5′-Bromo-2,2′-Bithiophen-5-yl) benzenesulfonic acid 2,2-dimethylpropyl ester) is shown below.
TLC; R f = 0.07 (toluene)
1 H-NMR (400 MHz, CDCl 3 , TMS, rt); δ 7.89 (d, J = 8 Hz, 2H), 7.72 (d, J = 8 Hz, 2H), 7.35 (d, J = 4 Hz, 1H), 7.12 (d, J = 4 Hz, 1H), 7.00 (d, J = 4 Hz, 1H), 6.98 (d, J = 4 Hz, 1H), 3.71 (s, 2H), 0.92 (s, 9H).

上記で得た化合物20(0.091 g, 0.20 mmol)、4-(ジメチルアミノ)フェニルボロン酸(0.038 g, 0.23 mmol)をトルエン10 mlとメタノール5 mlの混合溶媒に溶解し、更に1.0 M Na2CO3 aq 5 mlとPd(PPh3)4 (0.017 g, 15.0 μmol)を加え、脱気と N置換を3回行い、80℃で19時間攪拌した。放冷後、トルエンを加えて有機層を抽出し、飽和食塩水で洗浄した後 Na2SO4で乾燥させた。溶媒減圧除去し、シリカゲルクロマトグラフィー(溶離液;クロロホルム)で分離精製して黄色固体(化合物21)(0.030g, 29%)を得た。以下に生成した化合物21(4-(5'- (4-(Dimethylamino)phenyl)-2,2'-Bithiophen-5-yl) benzenesulfonic acid 2,2-dimethylpropyl ester)の分析結果を示す。
TLC; Rf = 0.36 (クロロホルム)
1H-NMR (400 MHz, CDCl3, TMS, r.t.): δ 7.87 (d, J = 8 Hz, 2H), 7.71 (d, J = 8Hz, 2H), 7.47 (d, J = 9 Hz, 2H), 7.35 (d, J = 4 Hz, 1H), 7.15 (m, 2H), 7.07 (d, J = 4 Hz, 1H), 6.71 (d, J = 9 Hz, 2H), 3.69 (s, 2H), 2.99 (s, 6H), 0.91 (s, 9H).
Compound 20 (0.091 g, 0.20 mmol) and 4- (dimethylamino) phenylboronic acid (0.038 g, 0.23 mmol) obtained above were dissolved in a mixed solvent of 10 ml of toluene and 5 ml of methanol, and further 1.0 M Na 2. CO 3 aq 5 ml and Pd (PPh 3 ) 4 (0.017 g, 15.0 μmol) were added, degassing and N 2 substitution were performed three times, and the mixture was stirred at 80 ° C. for 19 hours. After allowing to cool, toluene was added to extract the organic layer, washed with saturated brine, and dried over Na 2 SO 4 . The solvent was removed under reduced pressure, and the residue was separated and purified by silica gel chromatography (eluent: chloroform) to give a yellow solid (Compound 21) (0.030 g, 29%). The analysis results of Compound 21 (4- (5 ′-(4- (Dimethylamino) phenyl) -2,2′-Bithiophen-5-yl) benzenesulfonic acid 2,2-dimethylpropyl ester) produced below are shown.
TLC; R f = 0.36 (chloroform)
1 H-NMR (400 MHz, CDCl 3 , TMS, rt): δ 7.87 (d, J = 8 Hz, 2H), 7.71 (d, J = 8 Hz, 2H), 7.47 (d, J = 9 Hz, 2H ), 7.35 (d, J = 4 Hz, 1H), 7.15 (m, 2H), 7.07 (d, J = 4 Hz, 1H), 6.71 (d, J = 9 Hz, 2H), 3.69 (s, 2H ), 2.99 (s, 6H), 0.91 (s, 9H).

実施例1
本実施例では、合成例1〜5で得たチオフェン誘導体(化合物1、16、19及び21)及びフラン誘導体(化合物13)を極性の異なる様々な溶媒中でのケイ光スペクトルを測定した。
これらチオフェン誘導体及びフラン誘導体を、様々な溶媒(トルエン、1,4-ジオキサン、テトラヒドロフラン(THF)、酢酸エチル、クロロホルム、ジクロルメタン、アセトン、N,N-ジメチルホルムアミド(DMF)、ジメチルスルホキシド(DMSO)、アセトニトリル、エタノール、メタノール)に溶解させた。これらはいずれも良好に溶解した。
なお、各溶媒の溶媒極性ET(30) (kcal/mol)を、吸光型ソルバトクロミック色素である下式のベタイン色素を溶媒に溶かし、その吸収極大波長λ(nm)を式 ET(30) = 28591 / λ に代入して得た。

Figure 0005319130
Example 1
In this example, fluorescence spectra of the thiophene derivatives (Compounds 1, 16, 19 and 21) and furan derivatives (Compound 13) obtained in Synthesis Examples 1 to 5 in various solvents having different polarities were measured.
These thiophene derivatives and furan derivatives are mixed with various solvents (toluene, 1,4-dioxane, tetrahydrofuran (THF), ethyl acetate, chloroform, dichloromethane, acetone, N, N-dimethylformamide (DMF), dimethyl sulfoxide (DMSO), (Acetonitrile, ethanol, methanol). All of these dissolved well.
In addition, the solvent polarity E T (30) (kcal / mol) of each solvent is dissolved in the solvent of the following formula betaine dye, which is an absorption type solvatochromic dye, and the absorption maximum wavelength λ (nm) is expressed by the formula E T ( 30) = Obtained by substituting for 28591 / λ.
Figure 0005319130

これらチオフェン誘導体及びフラン誘導体を、0.5〜1.8 x 10-5 Mの濃度でスペクトル測定用標準溶媒(和光純薬工業社製)の溶液を調製し可視紫外分光光度計(日本分光株式会社製V-560 UV/VIS Spectrophotometer)で測定した。吸収極大波長(nm)を表1に、吸収極大波長におけるモル吸収係数(mol-1cm-1)を表2に示す。表中、化合物番号をNo.で表す。

Figure 0005319130
A solution of a standard solvent for spectrum measurement (manufactured by Wako Pure Chemical Industries, Ltd.) at a concentration of 0.5 to 1.8 × 10 −5 M was prepared from these thiophene derivatives and furan derivatives, and a visible ultraviolet spectrophotometer (V-manufactured by JASCO Corporation) 560 UV / VIS Spectrophotometer). Table 1 shows the absorption maximum wavelength (nm), and Table 2 shows the molar absorption coefficient (mol -1 cm -1 ) at the absorption maximum wavelength. In the table, the compound number is No. Represented by
Figure 0005319130

Figure 0005319130
Figure 0005319130

次に、これらチオフェン誘導体及びフラン誘導体のケイ光スペクトルを測定した。蛍光スペクトルは、吸収スペクトルと同じサンプルを用いて、ケイ光分光光度計(日立製作所製F-4500)で測定した。蛍光量子収率(Q)は、硫酸キニーネの0.5M硫酸溶液(QR = 0.546)を基準物質とし、サンプルと基準物質を365 nmで励起した時の蛍光発光スペクトルを測定し、下式から算出した。ここで、Iはサンプルの蛍光スペクトルの面積、IRは基準物質の蛍光スペクトルの面積、Aはサンプルの365 nmの吸光度、ARは365 nmの吸光度、nはサンプルを溶かした溶媒の屈折率、nRは0.5M硫酸の屈折率を示す。

Figure 0005319130
Next, the fluorescence spectra of these thiophene derivatives and furan derivatives were measured. The fluorescence spectrum was measured with a fluorescence spectrophotometer (F-4500, manufactured by Hitachi, Ltd.) using the same sample as the absorption spectrum. The fluorescence quantum yield (Q) was calculated from the following equation by measuring the fluorescence emission spectrum when the sample and the reference substance were excited at 365 nm using a 0.5M sulfuric acid solution of quinine sulfate (QR = 0.546) as the reference substance. . Where I is the area of the fluorescence spectrum of the sample, IR is the area of the fluorescence spectrum of the reference substance, A is the absorbance at 365 nm of the sample, AR is the absorbance at 365 nm, n is the refractive index of the solvent in which the sample is dissolved, nR Indicates the refractive index of 0.5 M sulfuric acid.
Figure 0005319130

ケイ光発光極大波長(nm)を表3に、ケイ光量子収率を表4に示す。また、化合物1のケイ光スペクトルを図9に示す。表中、化合物番号をNo.で表す。

Figure 0005319130
Table 3 shows the maximum fluorescence emission wavelength (nm), and Table 4 shows the fluorescence quantum yield. Further, the fluorescence spectrum of Compound 1 is shown in FIG. In the table, the compound number is No. Represented by
Figure 0005319130

Figure 0005319130
Figure 0005319130

ケイ光発光の波長は、溶媒の極性が上がるほど、長波長にシフトし、目視で識別できるほどケイ光色が変化した。即ち、上記化合物が分子周辺の溶媒極性によってケイ光波長が変わるケイ光ソルバトクロミック色素であることがわかる。   The wavelength of fluorescence emission shifted to a longer wavelength as the polarity of the solvent increased, and the fluorescence color changed so that it could be identified visually. That is, it can be seen that the compound is a fluorescent solvatochromic dye whose fluorescent wavelength changes depending on the solvent polarity around the molecule.

本発明のチオフェン誘導体の製法を示す図である。図中の番号は化合物の番号を示す。It is a figure which shows the manufacturing method of the thiophene derivative of this invention. The numbers in the figure indicate the compound numbers. タンパク質を本発明の色素化合物でラベル化する反応を示す図である。(1)及び(2)は、アミノ基含有アミノ酸を含むタンパク質、(3)は、チオール基含有アミノ酸を含むタンパク質、(4)は、カルボキシル基含有アミノ酸を含むタンパク質のラベル化方法を示す。It is a figure which shows reaction which labels protein with the pigment | dye compound of this invention. (1) and (2) are proteins containing amino group-containing amino acids, (3) is a protein containing thiol group-containing amino acids, and (4) is a method for labeling proteins containing carboxyl group-containing amino acids. 核酸配列を本発明の色素化合物でラベル化する反応を示す図である。It is a figure which shows reaction which labels a nucleic acid sequence with the pigment | dye compound of this invention. 本発明のチオフェン誘導体(化合物1)の製法を示す図である。図中の番号は化合物の番号を示すIt is a figure which shows the manufacturing method of the thiophene derivative (compound 1) of this invention. The numbers in the figure indicate the compound numbers. 本発明のフラン誘導体(化合物13)の製法を示す図である。図中の番号は化合物の番号を示すIt is a figure which shows the manufacturing method of the furan derivative (compound 13) of this invention. The numbers in the figure indicate the compound numbers. 本発明のチオフェン誘導体(化合物16)の製法を示す図である。図中の番号は化合物の番号を示すIt is a figure which shows the manufacturing method of the thiophene derivative (compound 16) of this invention. The numbers in the figure indicate the compound numbers. 本発明のチオフェン誘導体(化合物19)の製法を示す図である。図中の番号は化合物の番号を示すIt is a figure which shows the manufacturing method of the thiophene derivative (compound 19) of this invention. The numbers in the figure indicate the compound numbers. 本発明のチオフェン誘導体(化合物21)の製法を示す図である。図中の番号は化合物の番号を示すIt is a figure which shows the manufacturing method of the thiophene derivative (compound 21) of this invention. The numbers in the figure indicate the compound numbers. 各種溶媒中の本発明のチオフェン誘導体(化合物1)のケイ光スペクトルを示す。The fluorescence spectrum of the thiophene derivative of the present invention (Compound 1) in various solvents is shown.

Claims (3)

下式
Figure 0005319130
(式中、Xは酸素原子(−O−)又は硫黄原子(−S−)を表し、
mは1〜4の整数を表し、
は、下記(a)〜(e)のいずれかを表し、
(a)−O−R(式中、Rは、アルキル基の側鎖を有するアルキル基を表す。)
(b)−Y(式中、Yはハロゲン原子又はハロゲン化アルキル基を表す。)
(c)−NH(CHNH(式中、nは1〜14の整数を表す。)
(d)−NH(CHNHCO(CHY(式中、n及びoはそれぞれ1〜14の整数を表し、Yはハロゲン原子を表す。)
(e)−NH(CHCH(式中、nは1〜20の整数を表す。)
及びRは、それぞれ同じであっても異なってもよく、水素原子、アルコキシ基、アシルアミノ基、アルキル基、ハロゲン置換アルキル基、アミノ基、ヒドロキシ基又はハロゲン原子を表し、但し、R及びRは共同して芳香族若しくはエーテル結合を含んでもよい脂肪族の5、6又は8員環を形成してもよく、R及びRは、それぞれ同じであっても異なってもよく、水素原子又はアルキル基を表し、R及びRは、それぞれ同じであっても異なってもよく、水素原子、又は置換基を有していてもよいアルキル基を表し、但し、R及びRは共同して芳香族若しくは脂肪族の5員環又は6員環を形成してもよく、R及びRは共同して芳香族若しくは脂肪族の5員環又は6員環を形成してもよい。)で表されるケイ光ソルバトクロミック色素。
The following formula
Figure 0005319130
(In the formula, X represents an oxygen atom (—O—) or a sulfur atom (—S—),
m represents an integer of 1 to 4,
R 1 represents any of the following (a) to (e):
(A) -O-R 8 (wherein, R 8 is. Represents an alkyl group having a side chain alkyl group)
(B) -Y (wherein Y represents a halogen atom or a halogenated alkyl group)
(C) —NH (CH 2 ) n NH 2 (wherein n represents an integer of 1 to 14)
(D) -NH (CH 2) n NHCO (CH 2) o Y ( wherein, n and o each represents an integer of 1 to 14, Y represents a halogen atom.)
(E) -NH (CH 2 ) n CH 3 (wherein n represents an integer of 1 to 20)
R 2 and R 3 may be the same or different and each represents a hydrogen atom, an alkoxy group, an acylamino group, an alkyl group, a halogen-substituted alkyl group, an amino group, a hydroxy group, or a halogen atom, provided that R 2 And R 3 together may form an aliphatic 5-, 6- or 8-membered ring which may contain an aromatic or ether bond, and R 4 and R 5 may be the same or different, respectively. Represents a hydrogen atom or an alkyl group, and R 6 and R 7 may be the same or different and each represents a hydrogen atom or an alkyl group which may have a substituent, provided that R 4 and R 6 may jointly form an aromatic or aliphatic 5-membered ring or 6-membered ring, and R 5 and R 7 together form an aromatic or aliphatic 5-membered ring or 6-membered ring May be. ) A fluorescent solvatochromic dye represented by
請求項1に記載のケイ光ソルバトクロミック色素を、アミノ基、水酸基、チオール基又はカルボキシル基を含有するアミノ酸を含むタンパク質若しくはペプチド又はポリ若しくはオリゴヌクレオチドに連結して形成されるケイ光ソルバトクロミック色素複合体。 A fluorescent solvatochromic formed by linking the fluorescent solvatochromic dye according to claim 1 to a protein, peptide, poly or oligonucleotide containing an amino group, a hydroxyl group, a thiol group, or a carboxyl group-containing amino acid. Dye complex. 請求項1に記載のケイ光ソルバトクロミック色素若しくは請求項2に記載のケイ光ソルバトクロミック色素複合体又はこれらを含む溶液に紫外線を照射する段階、及び該ケイ光ソルバトクロミック色素からの発光波長又は発光色を測定する段階から成る、該ケイ光ソルバトクロミック色素の周辺の極性を検査する方法。 The step of irradiating ultraviolet light to the fluorescent solvatochromic dye according to claim 1 or the fluorescent solvatochromic dye complex according to claim 2 or a solution containing them, and light emission from the fluorescent solvatochromic dye A method for inspecting the polarity around the fluorescent solvatochromic dye, comprising the step of measuring a wavelength or an emission color.
JP2008023492A 2007-04-27 2008-02-04 Keiko solvatochromic dye and method of use thereof Expired - Fee Related JP5319130B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2008023492A JP5319130B2 (en) 2007-04-27 2008-02-04 Keiko solvatochromic dye and method of use thereof

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2007118831 2007-04-27
JP2007118831 2007-04-27
JP2008023492A JP5319130B2 (en) 2007-04-27 2008-02-04 Keiko solvatochromic dye and method of use thereof

Publications (2)

Publication Number Publication Date
JP2008291210A JP2008291210A (en) 2008-12-04
JP5319130B2 true JP5319130B2 (en) 2013-10-16

Family

ID=40166273

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008023492A Expired - Fee Related JP5319130B2 (en) 2007-04-27 2008-02-04 Keiko solvatochromic dye and method of use thereof

Country Status (1)

Country Link
JP (1) JP5319130B2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5683967B2 (en) 2009-02-06 2015-03-11 五稜化学株式会社 Fluorescent solvatochromic dye
JP5783508B2 (en) * 2011-06-14 2015-09-24 国立大学法人広島大学 Solvatochromic dye and organic halogen compound detection method using the same
CN105859761B (en) * 2016-04-26 2018-06-26 丽水学院 A kind of synthetic method of aromatic borate ester compound
JP7028733B2 (en) * 2018-07-06 2022-03-02 トヨタ自動車株式会社 How to identify pollutants in fuel cell separators

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09204040A (en) * 1996-01-26 1997-08-05 Fuji Photo Film Co Ltd Photosensitive material and image recording method using the material
JPH10104781A (en) * 1996-10-02 1998-04-24 Fuji Photo Film Co Ltd Heat developable photosensitive material
WO2003080042A1 (en) * 2002-03-27 2003-10-02 Shionogi & Co., Ltd. Decomposition inhibitor for extracellular matrix of cartilage
JP2005119129A (en) * 2003-10-16 2005-05-12 Fuji Photo Film Co Ltd Lithographic original plate, making method of lithographic plate and lithographic method

Also Published As

Publication number Publication date
JP2008291210A (en) 2008-12-04

Similar Documents

Publication Publication Date Title
JP7383283B2 (en) Fluorescent probes and their manufacturing methods and uses
EP0898596B1 (en) Squarate dyes and their use in fluorescent sequencing method
EP3690002A1 (en) Fluorescent probe, preparation method therefor and use thereof
WO2018014820A1 (en) Fluorescent dye and preparation method and use thereof
CA2748313A1 (en) Novel fluorescent boron-substituted dipyrromethenes and use thereof for diagnosis
CN108690032A (en) A kind of fluorescent dye and its synthetic method of azophenlyene fused structure
JP5319130B2 (en) Keiko solvatochromic dye and method of use thereof
KR20170101360A (en) Compound based cyanine, labeling dye, kit and contrast medium composition for biomolecule comprising the same
CN108864056A (en) Near infrared fluorescent compound and its preparation method and application with AIE performance
Safir Filho et al. Visualization of intracellular lipid droplets using lipophilic benzothiazole-based push-pull fluorophores at ultralow concentration
KR102253839B1 (en) Labeling dye and kit comprising the same
JP5683967B2 (en) Fluorescent solvatochromic dye
WO2015083799A1 (en) Near-infrared quenching group
JP2009014369A (en) Fluorescent reagent for labeling biomolecules
KR101125057B1 (en) Compound for labeling material, intermediate therefor and process for producing the same
JP5437615B2 (en) Kaiko solvatochromic dye
CN113416196B (en) A kind of benzothiadiazole-TB compound and its synthesis method and application
JP6108341B2 (en) Kay ion sensor dye
WO2020246616A1 (en) Fluorescent probe for detection of enpp activity
JP6269956B2 (en) Furylthiazole compound
JP2010090268A6 (en) Kaiko solvatochromic dye
JP7479667B2 (en) Compound having a sulfonylaniline skeleton or a salt thereof, or organic fluorescent material having the same
JP2016196608A (en) Fluorescent dye
JP4929461B2 (en) High Fluorescence Quantum Yield Hydrophobic Fluorescent Probe, Biopolymer Detection Method Using It, and Interaction Detection Method between Biopolymers
CN112321549B (en) A kind of far-red light lysosome fluorescent probe and preparation method and application thereof

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20110128

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20120517

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20120611

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20120611

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20120612

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20120618

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120626

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20120612

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20120718

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20130611

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20130711

R150 Certificate of patent or registration of utility model

Ref document number: 5319130

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees